Join Michael Salgaller, NCI Invention Development and Marketing Unit, and Steven Ferguson, OTT Special Advisor, for a presentation on Technology Development and Commercialization: Impacting Pipelines and Bottom Lines. They will be speaking at the Therapeutics Area Partnerships (TAP) Oncology Conference, a specialized biopharmaceutical partnering event. This is a great opportunity to learn more about opportunities at the National Cancer Institute and ask questions.

Salgaller leads the Invention Development and Marketing Unit (IDMU) within the Technology Transfer Center at NCI. He has over 20 years of scientific and investment experience and is ready to help foster licensing and collaboration activities between your organization and NCI. Ferguson is a Special Advisor at OTT and brings 30+ years of experience on how to set up successful partnerships with NIH and utilize a variety of available opportunities for your own company.

They will be speaking on Thursday, June 10th at 2pm. To find out more about this opportunity, please visit TAP’s website.